AssurX’s CATSWeb Selected by Genzyme Corporation for Global Complaint Management Solution

January 23, 2007

AssurX’s CATSWeb Selected by Genzyme Corporation for Global Complaint Management Solution

MORGAN HILL, CA (January 23, 2007) – AssurX, Inc., the leader in enterprise quality management and regulatory compliance solutions, today announced that Genzyme Corporation has selected AssurX’s CATSWeb for its global complaint management system to be used for intake, investigation, and tracking of complaints from customers located in the United States, Europe and Asia.

According to Todd Snell, Director of Global Compliance Processes and Systems, “We conducted an extensive search and followed a rigorous selection process. In the end, we felt that CATSWeb’s ease of configurability allowed us to continue to adapt our processes and solutions to Genzyme’s increasing product portfolio, facilities, and international markets. CATSWeb’s flexibility and ease of use ensure that we can provide a common, global complaint system to our device, drug, and biologic businesses. CATSWeb’s zero-client architecture allows us to rapidly deploy our process and solution to new countries and partners without extensive software downloads or IT support.”

"CATSWeb ships with turnkey processes that are the culmination of over a decade's worth of life sciences domain expertise. Added to that is the ability to easily configure the system to address real-world business needs and adapt to the ever-changing business environment. We are pleased to see the system continue to win top ranking in these categories along with ease of use, internationalization, and integration," said Sal Lucido, Vice President, Enterprise Solutions.

About Genzyme
One of the world's leading biotechnology companies, Genzyme is dedicated to making a major positive impact on the lives of people with serious diseases. Founded in 1981 as a small start-up company, Genzyme today provides many established products and services helping patients in more than 80 countries. Genzyme is a leader in the effort to develop and apply the most advanced technologies in the life sciences. The company's products and services are focused on rare inherited disorders, kidney disease, orthopaedics, cancer, transplant and immune diseases, and diagnostic testing. Genzyme's commitment to innovation continues today with a substantial development program focused on these fields as well as heart disease and other areas of unmet medical need. For more information about Genzyme, visit their website at www.genzyme.com.

About AssurX, Inc.
AssurX, Inc., provides organizations with enterprise-wide global solutions for their quality management and compliance systems needs. With a choice of OnDemand services or OnPremise (licensed) software delivery options, AssurX offers CATSWeb – a flexible, comprehensive all-in-one solution that automates quality & regulatory compliance related processes so issues can be globally managed—from detection to corrective action to trend analysis. It helps collect, organize, analyze and share information to better manage and improve quality and compliance performance everywhere in your enterprise. More information about AssurX can be found at www.assurx.com.